Skip to main content

Table 2 Baseline characteristics of subjects (n = 19)

From: Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment

 

Mean

SD

Min

Max

Age (years)

44.5

11.1

28.0

68.0

Baseline ejection fraction (%)

62.1

6.0

48.0

75.0

Height (centimeters)

164.9

8.2

152.0

188.0

Actual weight (kilograms)

75.1

21.6

54.5

140.4

BMI (kilograms/meters2)

28.2

8.2

21.5

53.0

BSA (mg/m2)

1.9

0.3

1.6

2.5

Aspartate transaminase (AST) (IU/L)

26.2

4.0

18.0

33.0

Alanine transaminase (ALT) (IU/L)

27.2

12.1

8.0

62.0

Total bilirubin (mg/dL)

0.6

0.2

0.2

1.0

Creatinine (g/dL)

0.7

0.1

0.5

1.0